Company intelligence / Profile preview

AccuraDX

Natick, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

AccuraDX commercializes genomics technologies for research applications. The company offers the KAS-Direct™ kit, which enables researchers to perform single-stranded DNA (ssDNA) labeling and enrichment in bulk live cells and fresh or frozen tissues[2]. The technology provides genome-wide mapping of active transcription and active enhancers[2].

Modalities: Research tool/Platform technology
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on AccuraDX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AccuraDX.

Explore the full profile